# A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome

> **NCT02074579** · PHASE2 · COMPLETED · sponsor: **Tsumura USA** · enrollment: 101 (actual)

## Conditions studied

- Irritable Bowel Syndrome in Females

## Interventions

- **DRUG:** TU-100
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02074579
- **Lead sponsor:** Tsumura USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2017-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02074579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02074579, "A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02074579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*